Table 1 Demographic and clinical characteristics of study samples used to establish the content validity of the ESD and EIS
Demographic and clinical characteristics | Concept Elicitation (n = 45) | Cognitive Debriefing (n = 31) |
|---|---|---|
Age | ||
Mean (Range) | 33.9 (18–44) | 36.3 (21–45) |
Country n (%) | ||
United States | 15 (33.3) | 19 (61.3) |
Germany | 15 (33.3) | 12 (38.7) |
France | 15 (33.3) | N/A |
Ethnic Background n (%)a | ||
Caucasian or White | 10 (66.7) | 8 (42.1) |
African American | 3 (20.0) | 9 (47.4) |
Other | 2 (13.3) | 2 (10.5) |
Education Level n (%) | ||
High school diploma or GED | 4 (8.9) | 3 (9.7) |
Some years of college | 8 (17.8) | 5 (16.1) |
Certificate program | 7 (15.6) | 9 (29.0) |
College or University degree | 1 (2.2) | 10 (32.3) |
Graduate or professional degree | 25 (55.6) | 4 (12.9) |
Experience of pain at screening n (%)b | ||
No pain (0) | 0 (0.0) | 1 (3.2)d |
Mild (1–4) | 16 (35.6) | 9 (29.0)d |
Moderate (5–6) | 14 (31.1) | 8 (25.8) |
Severe (7–10) | 15 (33.3) | 13 (41.9) |
Mean (range) | 5.8 (3–10) | 5.9 (0–10) |
Current treatment n (%)c | ||
Painkillers | 22 (48.9) | 19 (61.3) |
Oral contraceptives | 13 (28.9) | 11 (35.5) |
Other hormonal contraceptives | 3 (6.7) | 5 (16.1) |
GnRH analogue | 4 (8.9) | 5 (16.1) |
Progestin | 3 (6.7) | 1 (3.2) |
Other | 3 (6.7) | 1 (3.2) |